Medicus Pharma Closes $4.25M Equity Financings and $10.5M Debt Exchange with Streeterville Capital
Medicus Pharma Ltd. announced the closing of $4.25 million in fixed-price equity financings priced at-the-market, including a $1.25 million private placement led by CEO and other insiders with $750,000 from the Executive Chairman and CEO, and approximately $3.0 million via a registered direct offering. The company also exchanged $10.5 million of outstanding indebtedness held by Streeterville Capital, LLC for 105,000 preferred shares carrying an 8% cumulative annual dividend payable in kind. The company believes...
Key takeaways
$4.25 million total equity financing includes $1.25 million CEO-led private placement and approximately $3.0 million registered direct offering
Registered direct offering issued 97,973 common shares plus pre-funded warrants for 1,646,213 common shares at $1.72 per share
Private placement issued 726,730 common shares at $1.72 per share to insiders including 616,272 shares to related parties
$10.5 million debt exchange with Streeterville Capital exchanged for 105,000 preferred shares at $100 per share
Preferred shares carry 8% cumulative annual dividend payable in kind and are redeemable at company's option
Approximately $350,000 of common shares sold via ATM program since September 30, 2026
Company believes transactions restored shareholders' equity above Nasdaq $2.5 million threshold
Key metrics
Primary source
TickerStar generated this brief from an official company, investor-relations, earnings-call, or regulatory source. Review the primary material before making an investment decision.
Open SEC filingFollow MDCX in real time
Get material earnings, filing, IR, and earnings-call alerts by email.